Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ALS LIMITED Board/Management Information 2009

Sep 28, 2009

64365_rns_2009-09-28_4b66a900-e45d-438e-8391-e9060269c480.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [207 x 83] intentionally omitted <==

asx/media release

29 September 2009

Appointment of Non-Executive Director

Campbell Brothers Limited (ASX Code: CPB) today announced the appointment of Mr Mel Bridges as a non-executive Director of the Company, filling the vacancy left following the retirement of Mr Tony Love in July 2009.

Mel Bridges has over 30 years experience in the biotechnology and healthcare industries, underpinned by a Bachelor of Applied Science degree, and has knowledge and experience in respect to laboratory services and associated businesses, including global distribution.

He is currently the Chairman of Alchemia Limited and Impedimed Limited and a nonexecutive director of several other ASX-listed companies.

In welcoming Mel to the Company, the Chairman, Geoff McGrath said “Mel has the technical background and business experience required to add-value to the current board of Campbell Brothers and we look forward to his contribution”.

ENDS:

For further information:

Greg Kilmister, Managing Director, Campbell Brothers Limited, +61 7 3367 7900

1